Top Markets
Coin of the day
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUY
Pozycja w akcjach #183
Fresenius SE & Co. KGaA, a health care company, provides products and services... Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Cena akcji
$12.65
Kapitalizacja rynkowa
$114.00B
Zmiana (1 dzień)
1.36%
Zmiana (1 rok)
3.52%
Kraj
DE
Handel Fresenius SE & Co. KGaA (FSNUY)

Kategoria

Marża operacyjna dla Fresenius SE & Co. KGaA (FSNUY)
Marża operacyjna na dzień July 2026 TTM: 9.45%
Według najnowszych raportów finansowych i ceny akcji Fresenius SE & Co. KGaA, bieżąca marża operacyjna (TTM) wynosi 9.45%. Na koniec 2023 wynosiła 5.13%.
Historia marży operacyjnej dla Fresenius SE & Co. KGaA od 2002 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 9.45% 15.81%
2024 8.16% 59.06%
2023 5.13% -40.28%
2022 8.59% -22.47%
2021 11.08% -8.35%
2020 12.09% -7.57%
2019 13.08% -1.28%
2018 13.25% -2.14%
2017 13.54% -9.01%
2016 14.88% 6.06%
2015 14.03% 4.70%
2014 13.40% -8.91%
2013 14.71% -4.85%
2012 15.46% -0.32%
2011 15.51% 2.44%
2010 15.14% 4.27%
2009 14.52% 21.30%
2008 11.97% -68.59%
2007 38.11% 2.01%
2006 37.36% -6.13%
2005 39.80% 6.05%
2004 37.53% 250.09%
2003 10.72% -0.65%
2002 10.79% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
15.67% -98.34%
US
18.60% -98.03%
SA
16.14% -98.29%
US
5.17% -99.45%
CN
15.01% -98.41%
US
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.